Physician profile
Baron L Hamman
NPI 1326002072
$9,600.88
in general payments reported to CMS, 2019-2025
26 companies · $1,759 in 2025
The $1,759 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,716 · 2020: $668 · 2021: $1,133 · 2022: $729 · 2023: $1,134 · 2024: $1,463 · 2025: $1,759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,833 · Consulting Fee: $980 · Travel and Lodging: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,832.90 |
| Consulting Fee | $980.00 |
| Travel and Lodging | $542.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $2,902.95 | 2019-2025 | Atriclip Laa Exclusion System |
| Edwards Lifesciences Corporation | $1,304.24 | 2019-2023 | Mitris Resilia Mitral Valve |
| Ethicon US, LLC | $1,304.02 | 2023-2025 | Harmonic, Prolene, Echelon; Endopath |
| Abiomed | $913.22 | 2020-2024 | Impella |
| Baxter Healthcare | $839.81 | 2021-2025 | Perclot, Tisseel, Floseal |
| Getinge USA Sales, LLC | $354.82 | 2019-2025 | Vasoview Hemopro 2, Heartstring III Proximal Seal |
| Abbott Laboratories | $231.85 | 2022-2024 | Epic |
| Medtronic Vascular, INC. | $211.71 | 2019 | |
| W. L. Gore & Associates, INC. | $208.34 | 2022-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Conformable Thoracic Endoprosthesis |
| Medtronic, INC. | $207.25 | 2022-2024 | Penditure |
| Terumo Bct, INC. | $203.26 | 2019 | |
| Bolton Medical INC | $177.69 | 2020-2025 | Treo Abdominal Stent-Graft System |
| E.R. Squibb & Sons, L.L.C. | $130.85 | 2023 | Opdivo |
| Maquet Cardiovascular L.L.C. | $126.58 | 2023 | Acrobat-I Stabilizer |
| Kls-Martin L.P. | $97.00 | 2023-2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Cardiovascular Systems Corporation | $89.11 | 2020 | |
| Depuy Synthes Sales INC. | $81.21 | 2024 | Matrixrib |
| Artivion, INC. | $37.95 | 2019-2020 | |
| Biocomposites INC | $36.19 | 2025 | Stimulan |
| Actelion Pharmaceuticals US, INC. | $27.68 | 2019 | |
| Livanova USA, INC. | $27.28 | 2020 | |
| Amgen INC. | $25.71 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.80 | 2020 | |
| Amarin Pharma, INC. | $16.36 | 2019 | |
| Mimedx Group, INC. | $15.77 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $12.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Baron Hamman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.